Ranolazine (Ranexa®) in the treatment of chronic stable angina.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Works matching IS 0741238X AND DT 2010 AND VI 27 AND IP 4
Results: 8
1
2
Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 4, p. 211, doi. 10.1007/s12325-010-0020-y
- By:
- Publication type:
- Article
3
Oral dose-ranging developmental toxicity study of an herbal supplement (NT) and gallic acid in rats.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 4, p. 250, doi. 10.1007/s12325-010-0021-x
- By:
- Publication type:
- Article
4
Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 4, p. 233, doi. 10.1007/s12325-010-0019-4
- By:
- Publication type:
- Article
5
Ranolazine (Ranexa®) in the treatment of chronic stable angina.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 4, p. 193, doi. 10.1007/s12325-010-0018-5
- By:
- Publication type:
- Article
6
Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 4, p. 223, doi. 10.1007/s12325-010-0024-7
- By:
- Publication type:
- Article
7
Serum vitamin D concentration and short-term mortality among geriatric inpatients in acute care settings.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 4, p. 245, doi. 10.1007/s12325-010-0025-6
- By:
- Publication type:
- Article
8
Heart rate in ischemic heart disease. The innovation of ivabradine: More than pure heart rate reduction.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 4, p. 202, doi. 10.1007/s12325-010-0030-9
- By:
- Publication type:
- Article